Niki BioSolutions Enters At The Market Offering Agreement On October 9, 2026; May Sell Common Stock Up To $1.40M Aggregate Maximum Offering Price
Niki BioSolutions, Inc., a Delaware corporation (the "Company," "Niki," "we," "our," or "us"), has entered into an at-the-market issuance sales agreement, dated October 9, 2026
Share
Why It Matters
Niki BioSolutions can now sell up to 1.40 million dollars of new stock. When a company does this, watch whether they actually use the money or if the stock price stays stable.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.